Highlights: Notice of positive opinion received from the European Medicines Agency for Orphan Medicinal Product Designation for NUZ-001 in Amyotrophic Lateral Sclerosis Orphan Designation offers 10 ...
Neurizon has been buoyed by the receipt of a positive opinion from the European Medicines Agency in relation to its ... Read ...
HotCopper.com on MSN10h
Neurizon's fast-track application for flagship drug in Europe received 'positively'While the final decision is set for next month, biotech player Neurizon’s (ASX:NUZ) hopes have been lifted with a view ...
Results indicated PMN310 was generally well-tolerated and monthly dosing can provide CSF levels adequate for target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback